CVSS: 5.4EPSS: 0%CPEs: 11EXPL: 0CVE-2023-42029 – IBM CICS TX cross-site scripting
https://notcve.org/view.php?id=CVE-2023-42029
IBM CICS TX Standard 11.1, Advanced 10.1, 11.1, and TXSeries for Multiplatforms 8.1, 8.2, 9.1 are vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. IBM X-Force ID: 266059. IBM CICS TX Standard 11.1, Advanced 10.1, 11.1 y TXSeries para multiplataformas 8.1, 8.2, 9.1 son vulnerables a cross site scripting. Esta vulnerabilidad permite a los usuarios incrustar código JavaScript arbitrario en la interfaz de usuario web, alterando así la funcionalidad prevista, lo que podría conducir a la divulgación de credenciales dentro de una sesión confiable. • https://exchange.xforce.ibmcloud.com/vulnerabilities/266059 https://www.ibm.com/support/pages/node/7063659 https://www.ibm.com/support/pages/node/7063663 • CWE-79: Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') •
CVSS: 8.8EPSS: 0%CPEs: 13EXPL: 0CVE-2023-42027 – IBM CICS TX cross-site request forgery
https://notcve.org/view.php?id=CVE-2023-42027
IBM CICS TX Standard 11.1, Advanced 10.1, 11.1, and TXSeries for Multiplatforms 8.1, 8.2, 9.1 are vulnerable to cross-site request forgery which could allow an attacker to execute malicious and unauthorized actions transmitted from a user that the website trusts. IBM X-Force ID: 266057. IBM CICS TX Standard 11.1, Advanced 10.1, 11.1 y TXSeries for Multiplatforms 8.1, 8.2, 9.1 son vulnerables a cross-site request forgery, lo que podría permitir a un atacante ejecutar acciones maliciosas y no autorizadas transmitidas por un usuario en el que confía el sitio web. ID de IBM X-Force: 266057. • https://exchange.xforce.ibmcloud.com/vulnerabilities/266057 https://www.ibm.com/support/pages/node/7063659 https://www.ibm.com/support/pages/node/7063664 • CWE-352: Cross-Site Request Forgery (CSRF) •
CVSS: 4.9EPSS: 0%CPEs: 9EXPL: 0CVE-2023-42031 – IBM CICS TX denial of service
https://notcve.org/view.php?id=CVE-2023-42031
IBM TXSeries for Multiplatforms, 8.1, 8.2, and 9.1, CICS TX Standard CICS TX Advanced 10.1 and 11.1 could allow a privileged user to cause a denial of service due to uncontrolled resource consumption. IBM X-Force ID: 266016. IBM TXSeries para multiplataformas, 8.1, 8.2 y 9.1, CICS TX Standard CICS TX Advanced 10.1 y 11.1 podría permitir que un usuario privilegiado provoque una Denegación de Servicio (DoS) debido al consumo incontrolado de recursos. ID de IBM X-Force: 266016. • https://exchange.xforce.ibmcloud.com/vulnerabilities/266061 https://www.ibm.com/support/pages/node/7056429 https://www.ibm.com/support/pages/node/7056433 • CWE-400: Uncontrolled Resource Consumption •
CVSS: 3.7EPSS: 0%CPEs: 12EXPL: 0CVE-2023-33849 – IBM CICS TX information disclosure
https://notcve.org/view.php?id=CVE-2023-33849
IBM TXSeries for Multiplatforms 8.1, 8.2, 9.1, CICS TX Standard, 11.1, CICS TX Advanced 10.1, and 11.1 could transmit sensitive information in query parameters that could be intercepted using man in the middle techniques. IBM X-Force ID: 257105. • https://exchange.xforce.ibmcloud.com/vulnerabilities/257105 https://www.ibm.com/support/pages/node/7001687 https://www.ibm.com/support/pages/node/7001695 https://www.ibm.com/support/pages/node/7001697 • CWE-311: Missing Encryption of Sensitive Data •
CVSS: 6.5EPSS: 0%CPEs: 12EXPL: 0CVE-2023-33848 – IBM CICS TX information disclosure
https://notcve.org/view.php?id=CVE-2023-33848
IBM TXSeries for Multiplatforms 8.1, 8.2, 9.1, CICS TX Standard, 11.1, CICS TX Advanced 10.1, and 11.1 could allow a privileged user to obtain highly sensitive information by enabling debug mode. IBM X-Force ID: 257104. • https://exchange.xforce.ibmcloud.com/vulnerabilities/257104 https://www.ibm.com/support/pages/node/7001647 https://www.ibm.com/support/pages/node/7001681 https://www.ibm.com/support/pages/node/7001683 • CWE-200: Exposure of Sensitive Information to an Unauthorized Actor •